MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,048,067 | -28.8% | 28,189 | -13.2% | 0.00% | -33.3% |
| Q4 2022 | $1,472,122 | -69.8% | 32,490 | -55.3% | 0.01% | -77.8% |
| Q2 2022 | $4,882,000 | +272.7% | 72,722 | +356.2% | 0.03% | +440.0% |
| Q1 2022 | $1,310,000 | +310.7% | 15,940 | +785.1% | 0.01% | +400.0% |
| Q3 2021 | $319,000 | -80.9% | 1,801 | -82.6% | 0.00% | -83.3% |
| Q2 2021 | $1,669,000 | +50.2% | 10,330 | +104.2% | 0.01% | -25.0% |
| Q4 2020 | $1,111,000 | -20.8% | 5,058 | -53.5% | 0.01% | 0.0% |
| Q4 2019 | $1,402,000 | +34.8% | 10,879 | +7.7% | 0.01% | -20.0% |
| Q2 2019 | $1,040,000 | -82.9% | 10,100 | -87.8% | 0.01% | -84.4% |
| Q1 2019 | $6,078,000 | +443.2% | 82,924 | +214.4% | 0.06% | +392.3% |
| Q4 2018 | $1,119,000 | +156.7% | 26,379 | +85.8% | 0.01% | +85.7% |
| Q1 2018 | $436,000 | +78.0% | 14,200 | -32.3% | 0.01% | +40.0% |
| Q3 2017 | $245,000 | – | 20,975 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |